Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01752920
Brief Title: Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

First Submitted : December 14, 2012
First Submitted that Met QC Criteria : December 17, 2012
First Posted : December 19, 2012 (Estimate)

Certification/Extension First Submitted : October 18, 2019
Certification/Extension First Submitted that Met QC Criteria : October 18, 2019
Certification/Extension First Posted : October 31, 2019

Last Update Submitted that Met QC Criteria : October 18, 2019
Last Update Posted : October 31, 2019